Author:
Williams Austin D.,LaRoy Jennifer,Le Tiana,Mangino Debra A.,Robson Mark E.,Heerdt Alexandra S.,Moo Tracy-Ann
Reference18 articles.
1. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast, and prostate cancer;Li;Science,1997
2. The clinical spectrum of PTEN mutations;Yehia;Publ Online,2020
3. Buys S.S., Dickson P., Domchek S.M., et al. NCCN Guidelines Version 2.2022 Genetic/Familial High-Risk Assessment: Breast, Ovarian, and Pancreatic Vanderbilt-Ingram Cancer Center. Published online 2022. Accessed July 9, 2022. 〈https://www.nccn.org/home/member〉〈-〉.
4. A clinical scoring system for selection of patients for PTEN mutation testing is proposed on the basis of a prospective study of 3042 probands;Tan;Am J Hum Genet,2011
5. Early onset, multiple, bilateral fibroadenomas of the breast: a case report;Im;BMC Women’s Health,2021